Compared to Estimates, Ventas (VTR) Q4 Earnings: A Look at Key Metrics
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) Tops Q4 FFO and Revenue Estimates
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.81 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to FFO of $0.76 per share a year ago.
Healthcare REIT Ventas beats quarterly FFO estimates on senior housing demand
Ventas posted better-than-expected funds from operations (FFO) for the fourth quarter on Wednesday, driven by strong demand for its assisted living and senior housing properties.
What's in the Offing for Ventas Stock This Earnings Season?
While VTR's Q4 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses may have hurt it.
Seeking Clues to Ventas (VTR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Ventas Stock Rises 11.7% in Six Months: Will the Trend Continue?
The aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio are likely to support VTR stock.
These 4%+ Yielding ‘Bond Proxies' Are Top Picks For Trump 2.0
Trump 2.0 is now only a bit less than a week off, and things are moving fast.
Ventas Reaches Mutually Beneficial Agreements With Brookdale
Agreements with Brookdale Senior Living highlight VTR's strategy to drive profitable growth in the senior housing business.
Here's Why You Should Retain Ventas Stock in Your Portfolio Now
Rising healthcare spending and aging population aid VTR's senior housing operating portfolio. However, competitive market and tenant concentration remain risks.
Ventas' Tenant Brookdale Opts Out to Exercise Lease Extension
Brookdale Senior Living, a tenant of VTR, chooses not to exercise the extension term of Master Lease.
Here's Why Ventas Stock is an Apt Portfolio Pick for Now
Rising senior citizens' population and favorable outpatient visit trends are likely to benefit VTR.
Ventas: Growth Set To Continue In The Years Ahead
Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple-net lease properties. The Q3 2024 results were solid and the company increased its normalized FFO midpoint outlook. With a valuation above private market alternatives and distressed peers, Ventas is tapping debt and equity markets to grow its portfolio and increase normalized FFO.
